Is Retevmo Tablet Available in India?

Retevmo is a targeted therapy to inhibit RET-positive genes and is particularly prescribed for advanced Non-Small Cell Lung Cancer (NSCLC) and advanced thyroid cancer. Many patients in India wonder whether they can access the Retevmo tablets in India. Currently, Retevmo is not approved in the Indian market, meaning it cannot be purchased as a locally registered medicine. However, Indian Pharma Network (IPN) can help facilitate its legal import under the Named Patient Program (NPP). This program allows eligible patients to access innovative treatments from countries where they are approved. The process involves a doctor’s prescription, regulatory permissions, and compliant import channels. Patients should always rely on trusted facilitators like IPN to ensure the safety, quality, and authenticity of medicines. We are here to guide you through every step of the process. Please call/WhatsApp: +91-9310090915 to know more.